Antibody Cocktails Lose Potency Against Omicron Super-Mutant, Early Tests Show

3
1029

DB: The antibody cocktail given to disgraced former president Donald Trump when he was struck down with COVID-19 last year appears to lose some effectiveness when faced with the heavily mutated Omicron variant.

The Wall Street Journal first reported on the results of preliminary tests from drugmaker Regeneron that appear to show a faded effectiveness of its antibody treatment against Omicron when compared to earlier mutations.

However, Regeneron said it won’t be able to say exactly how big of an impact the variant has on its treatment until further testing is carried out in the next few weeks. Dr. George Yancopoulos, Regeneron’s president, said the company is already testing alternative antibodies that could tackle Omicron if it is proven to cause a significant loss of efficacy.

“What we have to admit is, in the course of the past six days, our urgency has increased,” Yancopoulos told the newspaper. “What started out as a backup plan has now been made a lot more urgent.” Antibody cocktails are the only drugs that have been authorized to treat patients infected with COVID-19.



https://www.thedailybeast.com/regeneron-loses-potency-against-omicron-super-mutant-early-tests-show?ref=home

ATTENTION READERS

We See The World From All Sides and Want YOU To Be Fully Informed
In fact, intentional disinformation is a disgraceful scourge in media today. So to assuage any possible errant incorrect information posted herein, we strongly encourage you to seek corroboration from other non-VT sources before forming an educated opinion.

About VT - Policies & Disclosures - Comment Policy
Due to the nature of uncensored content posted by VT's fully independent international writers, VT cannot guarantee absolute validity. All content is owned by the author exclusively. Expressed opinions are NOT necessarily the views of VT, other authors, affiliates, advertisers, sponsors, partners, or technicians. Some content may be satirical in nature. All images are the full responsibility of the article author and NOT VT.

3 COMMENTS

  1. “What we have to admit is, in the course of the past six days, our urgency has increased,”

    The “foot soldiers” in this operation must derive much job satisfaction from the nature of their objective. 🧐

  2. Wait a minute. If the Omicrone variant just came on the scene, how did Regeneron have time to find enough test subjects for their antibody “medicines”? Why does VT continue to post this drivel without at least a little screening. Oh, I know. In their Vaxx vs. Antivaxx ballgame, this sort of stuff counts as a point for Vaxx. I think.

Comments are closed.